Yuichi Iwaki
2020
In 2020, Yuichi Iwaki earned a total compensation of $3M as President and Chief Executive Officer at MediciNova, a 21% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $264,116 |
|---|---|
| Option Awards | $2,098,085 |
| Salary | $586,924 |
| Other | $17,100 |
| Total | $2,966,225 |
Iwaki received $2.1M in option awards, accounting for 71% of the total pay in 2020.
Iwaki also received $264.1K in non-equity incentive plan, $586.9K in salary and $17.1K in other compensation.
Rankings
In 2020, Yuichi Iwaki's compensation ranked 3,897th out of 13,090 executives tracked by ExecPay. In other words, Iwaki earned more than 70.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,897 out of 13,090 | 70th |
Division Manufacturing | 1,550 out of 5,620 | 72nd |
Major group Chemicals And Allied Products | 584 out of 2,253 | 74th |
Industry group Drugs | 503 out of 1,953 | 74th |
Industry Pharmaceutical Preparations | 380 out of 1,458 | 74th |
Source: SEC filing on April 26, 2022.
Iwaki's colleagues
We found two more compensation records of executives who worked with Yuichi Iwaki at MediciNova in 2020.